CHRNA1 Gene Myasthenic Syndrome Congenital Slow-Channel Genetic Test
At DNA Labs UAE, we offer the CHRNA1 Gene Myasthenic Syndrome Congenital Slow-Channel Genetic Test for individuals who may be affected by this rare genetic disorder. This test helps in diagnosing and understanding the condition, allowing for appropriate treatment strategies and genetic counseling.
Test Details
The CHRNA1 gene is associated with a rare genetic disorder called congenital myasthenic syndrome, slow-channel type (CMS-SC). This disorder affects the neuromuscular junction, leading to muscle weakness and fatigue. Our NGS (Next-Generation Sequencing) genetic testing method allows for the analysis and sequencing of multiple genes simultaneously.
In the case of CMS-SC, NGS genetic testing can be performed to identify any mutations or variations in the CHRNA1 gene that may be responsible for the disorder. This involves obtaining a DNA sample, typically through a blood sample or cheek swab. The DNA is then sequenced using advanced technologies, allowing for the identification of any variations in the CHRNA1 gene.
By detecting mutations in the CHRNA1 gene, NGS genetic testing can provide a definitive diagnosis of CMS-SC. This information is crucial for determining appropriate treatment strategies and genetic counseling for affected individuals and their families.
Test Name
CHRNA1 Gene Myasthenic Syndrome Congenital Slow-Channel Genetic Test
Components
Price: 4400.0 AED
Sample Condition
Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery
3 to 4 Weeks
Method
NGS Technology
Test Type
Neurological Disorders
Doctor
Neurologist
Test Department
Genetics
Pre Test Information
Clinical History of Patient who is going for CHRNA1 Gene Myasthenic Syndrome Congenital Slow-Channel NGS Genetic DNA Test
A Genetic Counselling session to draw a pedigree chart of family members affected with CHRNA1 Gene Myasthenic Syndrome Congenital Slow-Channel
Genetic Lab in UAE
At DNA Labs UAE, we are dedicated to providing accurate and reliable genetic testing services. Our team of experts, including neurologists and geneticists, ensures that every test is performed with utmost precision and care. We understand the importance of genetic testing in diagnosing and managing genetic disorders, and we strive to deliver the highest quality services to our patients.
| Test Name | CHRNA1 Gene Myasthenic syndrome congenital slow-channel Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Neurological Disorders |
| Doctor | Neurologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for CHRNA1 Gene Myasthenic syndrome, congenital, slow-channel NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with CHRNA1 Gene Myasthenic syndrome, congenital, slow-channel |
| Test Details |
The CHRNA1 gene is associated with a rare genetic disorder called congenital myasthenic syndrome, slow-channel type (CMS-SC). This disorder affects the neuromuscular junction, leading to muscle weakness and fatigue. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze and sequence multiple genes simultaneously. In the case of CMS-SC, NGS genetic testing can be performed to identify any mutations or variations in the CHRNA1 gene that may be responsible for the disorder. NGS genetic testing for CHRNA1 gene mutations involves obtaining a DNA sample, typically through a blood sample or cheek swab. The DNA is then sequenced using advanced technologies, allowing for the identification of any variations in the CHRNA1 gene. By detecting mutations in the CHRNA1 gene, NGS genetic testing can provide a definitive diagnosis of CMS-SC. This information is crucial for determining appropriate treatment strategies and genetic counseling for affected individuals and their families. |
